Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Targeted Oncology|October 4, 2018
Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal DiseaseMaximilian HochmairTargeted Oncology|April 28, 2018
Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal DiseaseMaximilian HochmairAnti-Cancer Drugs|April 30, 2019
Intracranial remission with brigatinib rechallenge as fifth-line ALK inhibition therapy in a lung cancer patientMaximilian Hochmair, Christoph Weinlinger, Helmut ProschMemo|July 10, 2018
Pitfalls in the radiological response assessment of immunotherapyLucian Beer, Maximilian Hochmair, Helmut ProschTrends in Cancer|July 26, 2017
Metastasis: Circulating Tumor Cells in Small Cell Lung CancerGerhard Hamilton, Doris Moser, Maximilian HochmairAnti-Cancer Drugs|July 22, 2016
Complete remissions in afatinib-treated non-small-cell lung cancer patients with symptomatic brain metastasesMaximilian Hochmair, Sophia Holzer, Otto C BurghuberTranslational Lung Cancer Research|March 10, 2016
Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cellsGerhard Hamilton, Barbara Rath, Sophia Holzer, et al.Oncoscience|September 2, 2015
Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancerGerhard Hamilton, Barbara Rath, Lukas Klameth, et al.Marine Drugs|October 17, 2018
Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell LinesBarbara Rath, Maximilian Hochmair, Adelina Plangger, et al.Translational Oncology|October 1, 2021
Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cellsAdelina Plangger, Barbara Rath, Maximilian Hochmair, et al.Pageof 7